The report about the spleen lesion that disappeared came from DF. Not sure how you missed it or at least missed that it was a positive report. That's about as positive a report as you can get from a cancer trial.
You sound like a very nervous and scared investor to me with too much at risk. Maybe it's time for you to conclude whether it be 2 dolla or 20 dolla? Welcome to the world of biotech. Take the words of Karin to heart, there are no guarantees in life or in stocks. Sell on the open Monday and free yourself....................
I can't say really. But it seems whenever there is something considered to be very positive, the specialist aren't shy about being in the press touting their findings. And it doesn't seem to matter much which phase the trial is in. If the findings suggest something significant, they're out front. It will be a good thing when the experts get out front and hang their reputations and the reputation of the institution on the drug/trial. Maybe DF gave the Company specific mentionables they can expand on...or their specialists can expand on. No idea what was requested and what the objectives are.
News 
Market Data 
Discover 
